References
- Campbell, J., Chantrell, L. J. and Eastmond, R., Purification and partial characterization of rat intestinal cefuroxime axetil esterase. Biochem. Pharmacol., 36, 2317-2324 (1987) https://doi.org/10.1016/0006-2952(87)90597-1
- Gabrielsson, J. and Weiner, D., Pharmacokinetic and Pharmacodynamic data analysis: Concepts and applications. Swedich Pharmaceutical Press, Stockholm, (1997)
- Li, W., Escarpe, P. A., Eisenberg, E. J., Cundy, K. C., Sweet, C., Jakeman, K. J., Merson, J., Lew, W., Williams, M., Zhang, L., Kim, C. U., Bischofberger, N., Chen, M. S. and Mendel, D. B., Identification of GS 4104 as an orally bioavailable produrg of the influenza virus neuraminidase inhibitor GS 4071. Antimicrobial Agents and Chemotherapy, 42(3), 647-653 (1998) https://doi.org/10.1093/jac/42.5.647
- Micropartition system MPS-1: For separation of free from protein-bound microsolute. Amicon Division, W.R. Grace & Co., USA.
- Naesens, L., Balzarini, J., BIschofberger, N. and De Clercq, E., Antiretroviral activity and pharmacokinetics in mice of oral bis (pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(povaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl) adenine. Antimicrobial Agents and Chemotherapy, 40, 22-28 (1996)
- Ruiz-Carretero, P., Nacher, A., Merino-Sanjuan, M. and Casabo, V. G., Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. International Journal of pharmaceutics, 202, 89-96 (2000) https://doi.org/10.1016/S0378-5173(00)00420-8
- Okudaira, N., Tatebayashi, T., Speirs, G. C., Komiya, I.. and Sugiyama, Y., A study of the intestinal absorption of an estertype prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. The Journal of Pharmacology and Experimental Therapeutics, 294, 580-587 (2000)
- Shargel, L. and Yu, A., Applied Biopharmaceutics and Pharmacokinetics. Appleton & Lange, Stamford, (1999)
- Stoeckel, K., Hofheinz, W., Laneury, J. P., Duchene, P., Shedlofsky, S. and Blouin, R. A., Stability of cephalosporin prodrug esters in human intestinal juice: Implications for oral bioavailability. Antimicrobial Agents and Chemotherapy, 42, 2602-2606 (1998)
- Umemura, K., Ikeda, Y., Kondo, K., Nakashima, M., Naganuma, H., Hisaoka, M., Nishino, H. and Tajima, M., Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers. Antimicrobial Agents and Chemotherapy, 41, 2664-2669 (1997)
- Wilkins, J., Ashofteh, A., Setoda, D., Wheatley, W. S., Huigen, H. and Ling, W., Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding. Ther Drug Monit., 19(1), 83-87 (1997) https://doi.org/10.1097/00007691-199702000-00015